Accessibility Menu
Sana Biotechnology logo

Sana Biotechnology

(NASDAQ) SANA

Current Price$3.62
Market Cap$971.24M
Since IPO (2021)-90%
5 Year-82%
1 Year+28%
1 Month+6%

Sana Biotechnology Financials at a Glance

Market Cap

$971.24M

Revenue (TTM)

$0.00

Net Income (TTM)

-$241.99M

EPS (TTM)

-$0.94

P/E Ratio

-3.72

Dividend

$0.00

Beta (Volatility)

2.13 (High)

Price

$3.62

Volume

883,355.009

Open

$3.48

Previous Close

$3.49

Daily Range

$3.44 - $3.62

52-Week Range

$2.61 - $6.55

Estimated Earnings Date

Aug 10, 2026

SANA: Motley Fool Moneyball Superscore

52

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Sana Biotechnology

Industry

Biotechnology

Employees

142

CEO

Steven D. Harr, MD

Headquarters

Seattle, WA 98102, US

SANA Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-161.87%

Return on Capital

-79.65%

Return on Assets

-64.77%

Earnings Yield

-26.88%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$971.24M

Shares Outstanding

278.29M

Volume

883.36K

Avg. Volume

3.92M

Financials (TTM)

Gross Profit

-$2.39M

Operating Income

-$237.56M

EBITDA

-$187.06M

Operating Cash Flow

-$132.55M

Capital Expenditure

-$1.09M

Free Cash Flow

-$133.64M

Cash & ST Invst.

$101.14M

Total Debt

$75.33M

Sana Biotechnology Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$2.39M

N/A

Gross Margin

0.00%

N/A

Market Cap

$971.24M

N/A

Market Cap/Employee

$5.01M

N/A

Employees

194

N/A

Net Income

-$47.21M

+4.4%

EBITDA

-$44.82M

+2.0%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$101.14M

-3.4%

Total Debt

$75.33M

-17.5%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$60.45M

-22.8%

Short Term Debt

$14.88M

+14.4%

Return on Assets

-64.77%

N/A

Return on Invested Capital

-82.68%

N/A

Free Cash Flow

-$37.67M

+22.8%

Operating Cash Flow

-$37.38M

+23.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PHATPhathom Pharmaceuticals, Inc.
$10.63-2.03%
OCSOculis Holding AG
$13.65-1.62%
XNCRXencor, Inc.
$15.84-1.61%
NKTRNektar Therapeutics
$66.54-4.68%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$14.79+0.04%
AALAmerican Airlines Group
$18.31+0.01%
IBITiShares Bitcoin Trust
$33.90+0.02%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.40+0.04%

Questions About SANA

What is the current price of Sana Biotechnology?

Sana Biotechnology is trading at $3.59 per share.

What is the 52-week range for Sana Biotechnology?

Over the past 52 weeks, Sana Biotechnology has traded between $2.61 and $6.55.

How much debt does Sana Biotechnology have?

As of the most recent reporting period, Sana Biotechnology reported total debt of $75.33M.

How much cash does Sana Biotechnology have on hand?

Sana Biotechnology reported $88.00M in cash and cash equivalents in its most recent financial results.

What is Sana Biotechnology’s dividend yield?

Sana Biotechnology does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.